COM:NEWRON
Newron Pharmaceuticals
- Stock
Last Close
7.28
22/11 16:30
Market Cap
136.34M
Beta: -
Volume Today
28.77K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -7.71M - | -10.10M 30.88% | -22.82M 126.01% | -15.24M 33.22% | -5.28M 65.33% | -15.04M 184.65% | -20.21M 34.40% | -21.00M 3.91% | -14.90M 29.04% | -17.49M 17.39% | -16.20M 7.39% | |
depreciation and amortization | 39K - | 33K 15.38% | 71K 115.15% | 33K 53.52% | 48K 45.45% | 192K 300% | 206K 7.29% | 219K 6.31% | 209K 4.57% | 202K 3.35% | 201K 0.50% | |
deferred income tax | 2.12M - | -164K 107.72% | -2.92M 1,682.32% | -2.31M 21.01% | -3.14M 36.03% | -5.10M 62.46% | -1.97M 61.43% | -2.69M 36.59% | -2.51M 6.47% | 402K 115.99% | ||
stock based compensation | 833K - | 1.23M 47.66% | 2.25M 83.01% | 2.29M 1.51% | 1.74M 23.89% | 2.11M 21.16% | 2.13M 0.90% | 1.46M 31.28% | 762K 47.84% | 480K 37.01% | 197K 58.96% | |
change in working capital | -3.65M - | -1.07M 70.80% | 672K 163.04% | 24K 96.43% | 1.40M 5,741.67% | 3.00M 113.69% | -158K 105.27% | 1.23M 876.58% | 1.75M 42.79% | -882K 150.34% | 1.64M 285.49% | |
accounts receivables | 718K - | -1.27M 276.46% | 609K 148.07% | -9K 101.48% | 1.40M 15,677.78% | 2.99M 113.34% | -158K 105.28% | 1.23M 876.58% | 1.75M 42.79% | -882K 150.34% | ||
inventory | -69K - | 201K 391.30% | 63K 68.66% | 33K 47.62% | 5K - | |||||||
accounts payables | -718K - | |||||||||||
other working capital | -4.30M - | |||||||||||
other non cash items | -2.32M - | -100K 95.68% | 6.96M 7,060.00% | -6.69M 196.09% | -6.31M 5.64% | -1.11M 82.40% | -1.98M 77.77% | 5.19M 362.84% | 3.25M 37.45% | 6.20M 90.91% | 4.03M 35.05% | |
net cash provided by operating activities | -10.69M - | -10.00M 6.44% | -12.86M 28.65% | -19.58M 52.25% | -8.40M 57.09% | -15.95M 89.84% | -21.98M 37.75% | -15.59M 29.07% | -11.45M 26.58% | -11.09M 3.08% | -10.14M 8.58% | |
investments in property plant and equipment | -76K - | -16K 78.95% | -60K 275% | -69K 15% | -24K 65.22% | -34K 41.67% | -51K 50% | -34K 33.33% | -20K 41.18% | -18K 10% | -11K 38.89% | |
acquisitions net | 301K - | 881K - | 581K 34.05% | -8.44M 1,552.67% | 299K 103.54% | |||||||
purchases of investments | -6.95M - | -275K - | -3.06M - | -2.21M 27.52% | -1.70M 23.34% | -3.04M 79.03% | -981K 67.73% | |||||
sales maturities of investments | 2.03M - | 1.40M 30.90% | 3.00M - | 2.17M 27.55% | 1.63M 24.87% | 10.14M 520.44% | 2.74M 72.96% | 4.24M 54.62% | ||||
other investing activites | 1K - | 102K 10,100% | 119K 16.67% | 103K 13.45% | -15.56M 15,209.71% | -6K 99.96% | -881K 14,583.33% | -582K 33.94% | 8.44M 1,550.17% | -299K 103.54% | ||
net cash used for investing activites | 226K - | -6.86M 3,135.40% | 2.08M 130.39% | 1.43M 31.22% | -15.86M 1,206.14% | 2.96M 118.67% | -932K 131.47% | -616K 33.91% | 8.42M 1,466.88% | -317K 103.76% | 3.25M 1,123.97% | |
debt repayment | -357K - | -359K 0.56% | -360K 0.28% | -362K 0.56% | -364K 0.55% | -154K 57.69% | -163K 5.84% | -135K 17.18% | -169K 25.19% | -186K 10.06% | ||
common stock issued | 18.36M - | 29.09M 58.49% | 27.05M 7.03% | 23.80M 12.00% | 51K 99.79% | |||||||
common stock repurchased | ||||||||||||
dividends paid | ||||||||||||
other financing activites | -809K - | -701K 13.35% | -1.60M 128.25% | -1.48M 7.56% | 76K 105.14% | 17.50M 22,926.32% | 7.50M 57.14% | 15M 100% | ||||
net cash used provided by financing activities | -357K - | 17.19M 4,914.57% | 28.03M 63.09% | 25.09M 10.51% | 21.96M 12.46% | -27K 100.12% | 17.34M 64,311.11% | 7.37M 57.52% | 14.83M 101.37% | -186K 101.25% | -192K 3.23% | |
effect of forex changes on cash | ||||||||||||
net change in cash | -10.82M - | 330K 103.05% | 17.25M 5,128.79% | 6.94M 59.80% | -2.31M 133.24% | -13.02M 464.57% | -5.57M 57.21% | -8.84M 58.66% | 11.81M 233.57% | -11.60M 198.21% | -7.09M 38.89% | |
cash at beginning of period | 29.24M - | 18.43M 36.99% | 18.76M 1.79% | 36.01M 92.00% | 42.95M 19.26% | 40.64M 5.37% | 27.62M 32.03% | 22.05M 20.17% | 13.21M 40.08% | 25.02M 89.35% | 13.42M 46.34% | |
cash at end of period | 18.43M - | 18.76M 1.79% | 36.01M 92.00% | 42.95M 19.26% | 40.64M 5.37% | 27.62M 32.03% | 22.05M 20.17% | 13.21M 40.08% | 25.02M 89.35% | 13.42M 46.34% | 6.34M 52.79% | |
operating cash flow | -10.69M - | -10.00M 6.44% | -12.86M 28.65% | -19.58M 52.25% | -8.40M 57.09% | -15.95M 89.84% | -21.98M 37.75% | -15.59M 29.07% | -11.45M 26.58% | -11.09M 3.08% | -10.14M 8.58% | |
capital expenditure | -76K - | -16K 78.95% | -60K 275% | -69K 15% | -24K 65.22% | -34K 41.67% | -51K 50% | -34K 33.33% | -20K 41.18% | -18K 10% | -11K 38.89% | |
free cash flow | -10.76M - | -10.01M 6.95% | -12.92M 29.04% | -19.65M 52.08% | -8.43M 57.11% | -15.99M 89.70% | -22.03M 37.77% | -15.62M 29.08% | -11.46M 26.61% | -11.11M 3.10% | -10.15M 8.63% |
All numbers in (except ratios and percentages)